Latest Partnerships News

Alchemy Resources finished FY2026 with a sharply wider loss, lower cash and a smaller asset base, even as drilling delivered strong copper-gold results at Yellow Mountain and high-grade iron results at Valley Bore. The explorer has reshaped its portfolio, but its next phase still depends on exploration success and further funding.

Condor Energy has consolidated 100% ownership of its offshore Peru acreage and moved its 1 Tcf Piedra Redonda gas discovery closer to commercialisation. The company enters FY2027 with a larger resource base and stronger project control, but auditors have warned that additional funding is needed to sustain operations.

Ionic Rare Earths is pushing toward commercial magnet recycling in Belfast and the United States, but its FY2026 report flags a material uncertainty over its ability to continue as a going concern. The company reported a larger A$14.9 million loss and A$13.9 million in operating cash outflows, despite government support and new strategic partnerships.

Resonance Health has signed a 24-month alliance with London-based Image Analysis Group, making its quantitative MRI endpoints orderable across IAG’s global clinical-trial network. The opportunity is potentially significant, but remains uncontracted: two pilot studies come first, with no minimum revenue or volume commitments.

Australian Vanadium will pay $500,000 in cash, issue $1.25 million of shares and transfer a royalty to regain control of non-vanadium mineral rights at its Gabanintha project. The deal simplifies the project’s ownership structure, but the newly recovered nickel, copper and gold potential remains unproven and outside the current development case.

Zinc of Ireland has transformed from a small Irish zinc explorer into a metals technology developer, acquiring Meclex, raising A$5.5 million and advancing ARGO and VOLTA. The opportunity is substantial, but both technologies remain uncommercialised and the VOLTA partnership requires formal renewal.

Emyria has presented its regulated Australian psychedelic-treatment experience to the US FDA, putting clinical delivery systems rather than drug development at the centre of its US ambitions. The appearance raises the company’s profile, but does not yet disclose regulatory approval, a commercial agreement or a financial commitment.

EMVision has completed the first stage of a Melbourne Mobile Stroke Unit study, operating its portable brain scanner in homes, ambulances and a workplace. The small, non-diagnostic feasibility study produced strong usability results while pointing to a larger clinical validation step planned for next-generation units.

Cazaly Resources will replace managing director Tara French with mining executive Adrian Byass from 8 October, while launching a review of its exploration portfolio. Byass will receive a $325,000 annual salary and may be granted up to 7 million performance rights, subject to approval and conditions.

Basin Energy has secured a three-year research collaboration with James Cook University to investigate improved extraction and recovery of heavy rare earths at its Sybella-Barkly project. The deal carries no cash payment, but JCU will own the resulting project intellectual property and data.

Infratil has raised FY27 earnings guidance as data-centre demand accelerates across CDC and Longroad, with AI infrastructure now representing 73% of its NZ$22 billion asset base. The company is also sharpening its strategy around scaled growth platforms, contracted cash flows and selective new investments.

Volt Resources has secured US$5.4 million in fully government-funded support for its US graphite refinery and customer application centre. The award is positive for project funding, but the company’s ASX securities remain suspended as it works with the exchange to satisfy reinstatement requirements.